Skip to content

US · SLBT · BIOTECHNOLOGY

SL Science Holding Ltd (SLBT) intrinsic value and stock valuation

$0.55as of 2026-11-21 · Mkt cap 21.14M

Data updated · price as of 2026-11-21

IC valuationIntrinsic value, upside vs price and the fair-value band are available to Pro members.
P/E
Pro
P/B
Pro
P/S
Pro

Price history

Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.

SL Science Holding Ltd DCF and intrinsic value

InvestorsCraft values SLBT with the Chepakovich two-stage DCF model. How the model works · Run your own DCF prefilled from SLBT’s statements →

Healthcare · Biotechnology New York, NY 10018 sl-bio.com

How the business is doing

Fiscal 2023–2025, USD

Revenue
$2.2M
20232025
Net income
-$-3.82M
20232025
Free cash flow
-$-2.23M
20232025
Total equity
$2.28M
20232025

Is it expensive?

Each multiple against its own 15-year range, or against peers where no history is available

P/E
Pro
with Pro
P/B
Pro
with Pro
P/S
Pro
with Pro
EV/EBITDA
Pro
with Pro
P/EG
Pro
with Pro
P/TBV
Pro
with Pro

Financials

Statements by fiscal year

Fiscal 2023–2025, USD
202520242023
Revenue$2.2M$3.36M$880K
Operating income-$-3.84M-$-1.2M$100K
Net income-$-3.82M-$-1.19M$400K
Operating cash flow-$-1.91M$280K-$-2.45M
Capital expenditure-$-320K-$-10K-$-180K
Free cash flow-$-2.23M$270K-$-2.64M
Total assets$2.82M$5.93M$4.24M
Total debt$210K$0.00$550K
Net debt-$-1.05M-$-3.68M$270K
Total equity$2.28M$5.73M$3.57M
Cash and short-term investments$1.26M$3.68M$280K
Income statement
202520242023
Revenue$2.2M$3.36M$880K
Cost of revenue$1.42M$1.43M$140K
Gross profit$780K$1.93M$740K
Research and development expenses$2.07M$2.02M$0.00
Selling, general and administrative expenses$2.54M$1.11M$640K
Other expenses$0.00$0.00$0.00
Operating expenses$4.61M$3.13M$640K
Cost and expenses$6.03M$4.56M$780K
Interest income$40K$50K$0.00
Interest expense$0.00$0.00$0.00
Depreciation and amortization$90K$50K$40K
Ebitda-$-3.74M-$-1.15M$130K
Operating income-$-3.84M-$-1.2M$100K
Total other income/expenses, net$20K$60K$440K
Income before tax-$-3.82M-$-1.13M$530K
Income tax expense-$0.00$60K$130K
Net income-$-3.82M-$-1.19M$400K
Weighted average shares outstanding$0.00$0.00$0.00
Weighted average diluted shares outstanding$0.00$0.00$0.00
Balance sheet
202520242023
Cash and short-term investments$1.26M$3.68M$280K
Net receivables$130K$270K$120K
Inventory$0.00$1.36M$1.48M
Total current assets$1.43M$5.86M$3.49M
Property, plant and equipment, net$460K$30K$740K
Goodwill and intangible assets$0.00$0.00$10K
Long-term investments$0.00$0.00$0.00
Total non-current assets$1.39M$80K$750K
Total assets$2.82M$5.93M$4.24M
Accounts payable$0.00$0.00$0.00
Short-term debt$150K$0.00$150K
Deferred revenue$0.00$0.00$0.00
Total current liabilities$470K$70K$180K
Long-term debt$60K$0.00$400K
Deferred revenue, non-current$0.00$0.00$0.00
Total non-current liabilities$60K$140K$490K
Capital lease obligations$210K$0.00$550K
Total liabilities$530K$200K$670K
Common stock$370K$370K$150K
Retained earnings-$-5.48M-$-1.66M$0.00
Accumulated other comprehensive income (loss)$470K$230K$0.00
Total equity$2.28M$5.73M$3.57M
Total investments$0.00$0.00$0.00
Total debt$210K$0.00$550K
Net debt-$-1.05M-$-3.68M$270K
Cash flow statement
202520242023
Net income-$-3.82M-$-1.19M$400K
Depreciation and amortization$90K$50K$40K
Stock-based compensation$0.00$0.00$0.00
Change in working capital$1.66M$1.27M-$-3.06M
Accounts receivable$0.00$30K-$-30K
Inventory$1.35M$190K-$-1.49M
Accounts payable$0.00$0.00$0.00
Net cash provided by operating activities-$-1.91M$280K-$-2.45M
Investments in property, plant and equipment-$-320K-$-10K-$-180K
Acquisitions, net$0.00$0.00$0.00
Net cash used for investing activities-$-320K$120K-$-180K
Common stock issued$0.00$7.24M$0.00
Common stock repurchased$0.00$0.00$0.00
Dividends paid$0.00$0.00$0.00
Net cash used for financing activities-$-880K$3.07M$2.86M
Net change in cash-$-2.88M$3.7M$220K
Cash at end of period$1.26M$4.14M$440K
Operating cash flow-$-1.91M$280K-$-2.45M
Capital expenditure-$-320K-$-10K-$-180K
Free cash flow-$-2.23M$270K-$-2.64M
USD millions

Line items

    USD millions

    Line items

      USD millions

      Line items

        About SL Science Holding Ltd

        Horizon Space Acquisition II Corp. aims to achieve strategic business combinations with other companies. This objective can be fulfilled through various transactional structures, including mergers, exchanges of shares, acquisitions of assets, direct purchases of stock, recapitalizations, or other forms of corporate reorganization. The firm was founded in 2023 and maintains its headquarters in New York, New York.

        CEO
        William Wang
        Employees
        2
        Beta
        0.09

        Explore

        Frequently asked questions

        What is the intrinsic value of SL Science Holding Ltd (SLBT)?

        InvestorsCraft does not currently publish an intrinsic value for SLBT. How the IC value is calculated.

        Is SLBT undervalued?

        InvestorsCraft does not publish an undervaluation signal for SLBT at this time.

        How is the intrinsic value calculated?

        InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.

        How often is this page updated?

        Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Nov 21, 2026.

        Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.